cabozantinib and Multiple-Myeloma

cabozantinib has been researched along with Multiple-Myeloma* in 2 studies

Trials

1 trial(s) available for cabozantinib and Multiple-Myeloma

Article	Year
Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma. Blood, 2016, 05-12, Volume: 127, Issue:19 Topics: Aged; Anilides; Female; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Protein Kinase Inhibitors; Pyridines; Receptor Protein-Tyrosine Kinases	2016

Other Studies

1 other study(ies) available for cabozantinib and Multiple-Myeloma

Article	Year
Market watch: Upcoming catalysts in Q2 2015. Nature reviews. Drug discovery, 2015, Volume: 14, Issue:4 Topics: Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Approval; Humans; Lung Neoplasms; Multiple Myeloma; Nivolumab; Pyridines; Receptor Protein-Tyrosine Kinases; United States; United States Food and Drug Administration	2015

Article

Year

Market watch: Upcoming catalysts in Q2 2015.

Nature reviews. Drug discovery, 2015, Volume: 14, Issue:4

Topics: Anilides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Approval; Humans; Lung Neoplasms; Multiple Myeloma; Nivolumab; Pyridines; Receptor Protein-Tyrosine Kinases; United States; United States Food and Drug Administration

2015